Paper3667166
A phase II study of (2"R)-4'-0-tetrahydropyranyladriamycin (THP) in hematological malignancies.
Yamada K and 9 others. Invest New Drugs, 1987. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. A phase II study of (2"R)-4'-0-tetrahydropyranyladriamycin (THP) in hematological malignancies. Papers, record 3667166. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3667166
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- A phase II study of (2"R)-4'-0-tetrahydropyranyladriamycin (THP) in hematological malignancies.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Doxorubicin | Major topic |
| Leukemia | Major topic |
| Lymphoma | Major topic |
| Acute Disease | |
| Adolescent | |
| Adult | |
| Aged | |
| Antineoplastic Combined Chemotherapy Protocols | |
| Child | |
| Drug Evaluation | |
| Female | |
| Humans | |
| Male | |
| Middle Aged |
Source PubMed
References14
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 4353012 | A clinicopathologic analysis of adriamycin cardiotoxicity. | Cancer | 1973 | https://conductscience.org/library/papers/4353012 | PubMed |
| 2 | 528373 | Tetrahydropyranyl derivatives of daunomycin and adriamycin. | J Antibiot (Tokyo) | 1979 | https://conductscience.org/library/papers/528373 | PubMed |
| 3 | 6882000 | [Preliminary phase II clinical study of 4'-O-tetrahydropyranyl doxorubicin (THP-ADM)]. | Gan To Kagaku Ryoho | 1983 | https://conductscience.org/library/papers/6882000 | PubMed |
| 4 | 6588924 | [Effects of single administration of tetrahydropyranyladriamycin (THP) in lymphoid malignancy]. | Gan To Kagaku Ryoho | 1984 | https://conductscience.org/library/papers/6588924 | PubMed |
| 5 | 5365804 | Adriamycin, 14-hydroxydaunomycin, a new antitumor antibiotic from S. peucetius var. caesius. | Biotechnol Bioeng | 1969 | https://conductscience.org/library/papers/5365804 | PubMed |
| 6 | 528374 | Low heart and skin toxicity of a tetrahydropyranyl derivative of adriamycin (THP-ADM) as observed by electron and light microscopy. | J Antibiot (Tokyo) | 1979 | https://conductscience.org/library/papers/528374 | PubMed |
| 7 | 6501106 | The absolute structures of THP-adriamycins. | J Antibiot (Tokyo) | 1984 | https://conductscience.org/library/papers/6501106 | PubMed |
| 8 | 6696455 | [Phase II study of 4'-O-tetrahydropyranyladriamycin(THP-ADM)]. | Gan To Kagaku Ryoho | 1984 | https://conductscience.org/library/papers/6696455 | PubMed |
| 9 | 4512953 | Daunorubicin in the therapy of acute granulocytic leukemia. | Cancer Res | 1973 | https://conductscience.org/library/papers/4512953 | PubMed |
| 10 | 6833151 | Rapid uptake by cultured tumor cells and intracellular behavior of 4'-O-tetrahydropyranyladriamycin. | J Antibiot (Tokyo) | 1983 | https://conductscience.org/library/papers/6833151 | PubMed |
| 11 | 6580842 | [Phase II study of THP-adriamycin in acute leukemia]. | Gan To Kagaku Ryoho | 1983 | https://conductscience.org/library/papers/6580842 | PubMed |
| 12 | 6202243 | [Acute cardiotoxicity of anthracyclines--analysis by using Holter ECG]. | Gan To Kagaku Ryoho | 1984 | https://conductscience.org/library/papers/6202243 | PubMed |
| 13 | 6678865 | Phase I clinical trial of a new anthracycline: 4'-o-tetrahydropyranyl adriamycin. | Invest New Drugs | 1983 | https://conductscience.org/library/papers/6678865 | PubMed |
| 14 | 7060020 | 4'-O-tetrahydropyranyladriamycin as a potential new antitumor agent. | Cancer Res | 1982 | https://conductscience.org/library/papers/7060020 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 40451863 | The outcome of patients with peripheral T cell lymphoma treated with doxorubicin-based (CHOP) and pirarubicin-based regimen (THP-COP) regimen: a single institution experience. | J Clin Exp Hematop | 2025 | https://conductscience.org/library/papers/40451863 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3667166
GET https://conductscience.org/api/papers/v1/3667166/authors